Literature DB >> 24980103

Rationale and benefit of using high throughput solubility screens in drug discovery.

Joseph J Goodwin1.   

Abstract

Over the past several years, drug companies have dedicated significant resources to address the 'biopharmaceutical properties' bottleneck that is recognized as a major source of high attrition rates and longer development times for new drugs. Although it is well accepted that aqueous solubility is a crucial physicochemical parameter that directly influences the passive absorption and distribution of orally administered drugs, there is less agreement about the effective measurement and strategic use of solubility data, especially in the earlier stages of the drug development process.: � 2006 Elsevier Ltd . All rights reserved.

Year:  2006        PMID: 24980103     DOI: 10.1016/j.ddtec.2005.03.001

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  3 in total

1.  Solubility at the molecular level: development of a critical aggregation concentration (CAC) assay for estimating compound monomer solubility.

Authors:  Jie Wang; Edmund Matayoshi
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

2.  Automated solubility screening platform using computer vision.

Authors:  Parisa Shiri; Veronica Lai; Tara Zepel; Daniel Griffin; Jonathan Reifman; Sean Clark; Shad Grunert; Lars P E Yunker; Sebastian Steiner; Henry Situ; Fan Yang; Paloma L Prieto; Jason E Hein
Journal:  iScience       Date:  2021-02-12

Review 3.  QSPR studies on aqueous solubilities of drug-like compounds.

Authors:  Pablo R Duchowicz; Eduardo A Castro
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.